Add to ORKGDespite emerging data suggesting reduced antibody responses among SOT recipients following SARS-CoV-2 vaccine, critical unanswered questions remain. The clinical implications of the reduced humoral response need to be assessed through prospective studies. Studies are likewise needed to inform which vaccine dosing strategies result in improved immunity and if such approaches maximize protection against severe infection in the vulnerable transplant population
Solid organ transplant recipients (SOTRs) show higher rates of COVID-19 breakthrough infection than ...
Allogeneic haematopoietic cell transplantation (allo-HCT) recipients show impaired antibody (Ab) res...
Waning vaccine-induced immunity coupled with the emergence of SARS-CoV-2 variants has led to increas...
Despite emerging data suggesting reduced antibody responses among solid organ transplant recipients ...
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid o...
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid o...
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid o...
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid o...
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid o...
peer reviewedAs solid organ transplant recipients are at high risk of severe COVID-19 and respond po...
peer reviewedAs solid organ transplant recipients are at high risk of severe COVID-19 and respond po...
Importance: Recipients of solid organ transplant (SOT) experience decreased immunogenicity after COV...
INTRODUCTION: Inadequate antibody response to mRNA SARS-CoV-2 vaccination has been described among k...
Background: Since phase III trials for the most prominent vaccines excluded immunocompromised or imm...
Patients with hematological malignancies have been excluded from the new zoonotic coronavirus (sever...
Solid organ transplant recipients (SOTRs) show higher rates of COVID-19 breakthrough infection than ...
Allogeneic haematopoietic cell transplantation (allo-HCT) recipients show impaired antibody (Ab) res...
Waning vaccine-induced immunity coupled with the emergence of SARS-CoV-2 variants has led to increas...
Despite emerging data suggesting reduced antibody responses among solid organ transplant recipients ...
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid o...
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid o...
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid o...
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid o...
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid o...
peer reviewedAs solid organ transplant recipients are at high risk of severe COVID-19 and respond po...
peer reviewedAs solid organ transplant recipients are at high risk of severe COVID-19 and respond po...
Importance: Recipients of solid organ transplant (SOT) experience decreased immunogenicity after COV...
INTRODUCTION: Inadequate antibody response to mRNA SARS-CoV-2 vaccination has been described among k...
Background: Since phase III trials for the most prominent vaccines excluded immunocompromised or imm...
Patients with hematological malignancies have been excluded from the new zoonotic coronavirus (sever...
Solid organ transplant recipients (SOTRs) show higher rates of COVID-19 breakthrough infection than ...
Allogeneic haematopoietic cell transplantation (allo-HCT) recipients show impaired antibody (Ab) res...
Waning vaccine-induced immunity coupled with the emergence of SARS-CoV-2 variants has led to increas...